Lynn Darden Kramer
Lynn Darden Kramer publishes mostly in Psychiatry and Mental health, Physiology and Molecular Biology, on topics such as Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research and Epilepsy research and treatment.
- World rank
- #458,692 of 7,710,434 ranked researchers
- Rank in United States
- #160,929 of 1,627,098
- Works
- 92
- Citations
- 21k
- Citations per work
- 224.3
What does Lynn Darden Kramer research?
Lynn Darden Kramer's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (7%), Mathematics (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4447.4%
- Medicine4447.4%
- Everything else3841.0%
- Life Sciences66.8%
- Physical Sciences44.8%
- Mathematics44.8%
- 1Psychiatry and Mental health19% of their works
- 2Physiology19% of their works
- 3Molecular Biology7% of their works
- 4Pediatrics, Perinatology and Child Health5% of their works
- 5Statistics and Probability5% of their works
- 6Neurology4% of their works
Research topics
- Alzheimer's disease research and treatments
- Dementia and Cognitive Impairment Research
- Epilepsy research and treatment
- Statistical Methods in Clinical Trials
- Computational Drug Discovery Methods
- Pharmacological Effects and Toxicity Studies
- Neuroscience and Neuropharmacology Research
- Cholinesterase and Neurodegenerative Diseases
Which keywords describe Lynn Darden Kramer's research?
The keywords of their largest research topics: Oxidative Stress, Amyloid Hypothesis, Tau Pathology, Biomarkers, Alzheimer's Disease, Dementia, Mild Cognitive Impairment and Antiepileptic Drugs.
- Cholinesterase Inhibitors
- Synaptic Plasticity
- Virtual Screening
- Prenatal Exposure
- False Discovery Rate
- Seizures
- Antiepileptic Drugs
- Dementia
- Biomarkers
- Amyloid Hypothesis
- Oxidative Stress
- Tau Pathology
- Alzheimer's Disease
- Mild Cognitive Impairment
- Epilepsy
- Adaptive Designs
- Molecular Docking
- Teratogenicity
- Neurotransmission
- Acetylcholinesterase
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Oxidative Stress542 topics
- Amyloid Hypothesis451 topic
- Tau Pathology451 topic
- Biomarkers442 topics
- Alzheimer's Disease382 topics
- Dementia331 topic
- Mild Cognitive Impairment331 topic
- Antiepileptic Drugs212 topics
- Epilepsy121 topic
- Seizures121 topic
- Adaptive Designs111 topic
- False Discovery Rate111 topic
- Molecular Docking91 topic
- Prenatal Exposure91 topic
- Teratogenicity91 topic
- Virtual Screening91 topic
- Neurotransmission61 topic
- Synaptic Plasticity61 topic
- Acetylcholinesterase51 topic
- Cholinesterase Inhibitors51 topic
Where does Lynn Darden Kramer work?
Lynn Darden Kramer's main affiliation in the publication record is Eisai (United States), United States.
How many publications and citations does Lynn Darden Kramer have?
OpenAlex counts 92 works and 20,634 citations for Lynn Darden Kramer, an h-index of 28, ranking #458,692 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lynn Darden Kramer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.